StockData
Sigyn Therapeutics, Inc. logo

Sigyn Therapeutics, Inc. (SIGY) stock

SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 0/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $48.16KP/E –Yield –

Sigyn Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sigyn Therapeutics's operating cash flow for the twelve months ending Sep 30, 2025 was -$936.43K. For fiscal 2024 it was -$872.44K. The highest annual figure on record is -$44.44K in fiscal 2014.

Annual operating cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$872.44K–
FY2023Dec 31, 2023-$1.38M–
FY2022Dec 31, 2022-$1.83M–
FY2021Dec 31, 2021-$1.77M–
FY2020Dec 31, 2020-$829.81K–
FY2019Dec 31, 2019-$143.68K–
FY2018Dec 31, 2018-$286.11K–
FY2017Dec 31, 2017-$400.00K–
FY2015Dec 31, 2015-$83.82K–
FY2014Dec 31, 2014-$44.44K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$199.33K–
Q2 FY2025Jun 30, 2025-$152.44K–
Q1 FY2025Mar 31, 2025-$294.45K–
Q4 FY2024Dec 31, 2024-$290.22K–
Q3 FY2024Sep 30, 2024-$163.81K–
Q2 FY2024Jun 30, 2024-$182.79K–
Q1 FY2024Mar 31, 2024-$235.61K–
Q4 FY2023Dec 31, 2023-$127.89K–
Q3 FY2023Sep 30, 2023-$364.05K–
Q2 FY2023Jun 30, 2023-$328.69K–
Q1 FY2023Mar 31, 2023-$562.57K–
Q4 FY2022Dec 31, 2022-$451.77K–
Q3 FY2022Sep 30, 2022-$524.17K–
Q2 FY2022Jun 30, 2022-$394.74K–
Q1 FY2022Mar 31, 2022-$459.57K–
Q4 FY2021Dec 31, 2021-$552.96K–
Q3 FY2021Sep 30, 2021-$539.69K–
Q2 FY2021Jun 30, 2021-$407.11K–
Q1 FY2021Mar 31, 2021-$274.42K–
Q4 FY2020Dec 31, 2020-$280.75K–
Q3 FY2020Sep 30, 2020-$201.97K–
Q2 FY2020Jun 30, 2020-$134.84K-1798.4%
Q1 FY2020Mar 31, 2020-$212.25K–
Q4 FY2019Dec 31, 2019-$30.01K-343.6%
Q3 FY2019Sep 30, 2019-$48.78K-263.1%
Q2 FY2019Jun 30, 2019$7.94K–
Q1 FY2019Mar 31, 2019-$72.83K–
Q4 FY2018Dec 31, 2018$12.32K–
Q3 FY2018Sep 30, 2018$29.92K+1330.8%
Q2 FY2018Jun 30, 2018-$6.51K–
Q1 FY2018Mar 31, 2018-$321.84K–
Q4 FY2017Dec 31, 2017-$218.95K–
Q3 FY2017Sep 30, 2017$2.09K–
Q2 FY2017Jun 30, 2017-$75.18K–
Q1 FY2017Mar 31, 2017-$107.96K–
Q3 FY2016Sep 30, 2016-$106.44K–
Q2 FY2016Jun 30, 2016-$165.58K–
Q1 FY2016Mar 31, 2016-$317.57K–
Q4 FY2015Dec 31, 2015-$78.28K–

More Sigyn Therapeutics figures

See a number that looks wrong?